| 000 | 01873 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517174028.0 | ||
| 264 | 0 | _c20180703 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.01695-17 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHassounah, Said A | |
| 245 | 0 | 0 |
_aAntiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _c12 2017 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAmides |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 |
_aHIV Integrase _xgenetics |
| 650 | 0 | 4 |
_aHIV Integrase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xpharmacology |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 4 or More Rings _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aOxazines |
| 650 | 0 | 4 | _aPiperazines |
| 650 | 0 | 4 |
_aPyridones _xpharmacology |
| 650 | 0 | 4 |
_aRaltegravir Potassium _xpharmacology |
| 650 | 0 | 4 | _aReverse Genetics |
| 650 | 0 | 4 |
_aSimian Immunodeficiency Virus _xdrug effects |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _aAlikhani, Ahmad | |
| 700 | 1 | _aOliveira, Maureen | |
| 700 | 1 | _aBharaj, Simrat | |
| 700 | 1 | _aIbanescu, Ruxandra-Ilinca | |
| 700 | 1 | _aOsman, Nathan | |
| 700 | 1 | _aXu, Hong-Tao | |
| 700 | 1 | _aBrenner, Bluma G | |
| 700 | 1 | _aMesplède, Thibault | |
| 700 | 1 | _aWainberg, Mark A | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 61 _gno. 12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01695-17 _zAvailable from publisher's website |
| 999 |
_c27578483 _d27578483 |
||